Back
Neurocrine Biosciences, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
NBIX
Neurocrine Biosciences, Inc.
Last Price:
$122.87
Seasonality Move:
-5.2%
7 Day Trial
ALL ACCESS PASS
$
7
Neurocrine Biosciences, Inc. Stock Forecast
-
Over the next 52 weeks, Neurocrine Biosciences, Inc. has on average historically risen by 27.3% based on the past 29 years of stock performance.
-
Neurocrine Biosciences, Inc. has risen higher in 19 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 65.52%
-
Is Neurocrine Biosciences, Inc. Stock Undervalued?The current Neurocrine Biosciences, Inc. [NBIX] share price is $137.44. The Score for NBIX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
NBIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Neurocrine Biosciences, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Neurocrine Biosciences, Inc. has on average historically risen by 27.3% based on the past 29 years of stock performance.
Neurocrine Biosciences, Inc. Stock Rating
Buy
52
Neurocrine Biosciences, Inc. (NBIX)
is a Buy
Is Neurocrine Biosciences, Inc. overpriced?
-
Neurocrine Biosciences, Inc. has risen higher in 19 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 65.52%
Neurocrine Biosciences, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurocrine.com
52-Week Data
52-Week High:
160.18
52-Week Low:
84.23
Prediction Charts
Market Cap:
13.7B
Price in USD:
137.44
Volume:
1.4M
Beta:
0.78
Technical Analysis
SMA50:
142.07
SMA100:
142.41
SMA200:
135.46
52-Wk Change:
17.62%
Stock Predictions
-
Is Neurocrine Biosciences, Inc. stock public?Yes, Neurocrine Biosciences, Inc. is a publicly traded company.
-
What is the Neurocrine Biosciences, Inc. stock quote today?The Neurocrine Biosciences, Inc. stock price is 137.44 USD today.
-
How to buy Neurocrine Biosciences, Inc. stock online?You can buy Neurocrine Biosciences, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-23 | 138.16 | 136.18 | 138.74 | 135.41 |
| Jan-26 | 134.36 | 134.51 | 136.21 | 134.11 |
| Jan-27 | 134.50 | 133.89 | 136.51 | 133.54 |
| Jan-28 | 133.01 | 134.66 | 137.45 | 132.75 |
| Jan-29 | 135.53 | 137.96 | 138.13 | 133.41 |
| Jan-30 | 136.63 | 136.06 | 137.95 | 134.96 |
| Feb-2 | 135.33 | 137.63 | 137.95 | 135.00 |
| Feb-3 | 137.04 | 138.98 | 141.24 | 137.04 |
| Feb-4 | 139.07 | 137.86 | 140.43 | 137.03 |
| Feb-5 | 136.46 | 137.93 | 141.45 | 136.46 |
| Feb-6 | 138.75 | 141.20 | 142.15 | 138.27 |
| Feb-9 | 141.02 | 139.56 | 141.09 | 138.50 |
| Feb-10 | 140.34 | 137.65 | 142.82 | 137.56 |
| Feb-11 | 136.99 | 137.44 | 139.83 | 135.02 |
Neurocrine Biosciences, Inc. Earnings
Neurocrine Biosciences, Inc. Earnings Report: Per Share Neurocrine Biosciences, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Neurocrine Biosciences, Inc. Forecast Revenue Growth
Neurocrine Biosciences, Inc. Stock Analysis: Historical quarterly revenues per share for Neurocrine Biosciences, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.33 per share, and an increase next year of $1.58 per share.
* Neurocrine Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.